🔗 Share this article

An underground market for unlicensed weight-loss medications is propelled by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Experimental Treatment Acquiring Popularity Via Social Media

Retatrutide, which is still in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are encouraged to message these accounts directly for supplier links, while also receiving discount codes.

Thriving Trade on Messaging Platforms

Separately, a robust trade exists on Telegram, where communities with thousands of members share “before and after” images, administration instructions and claims of next-day UK delivery. Sellers market the drug there before redirecting customers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Voice Concerns

However, physicians and pharmacists have cautions that the sale of what is still an unapproved medication in the UK is worrisome and could result in users injecting substances of uncertain source.

Some professionals said the demand for the experimental drug could be linked to the rising price of approved weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on social media or Telegram is illegal in the UK, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still breach medicines, advertising, and customer laws, risking fines, prosecution or imprisonment.

Platform Response and Content Removal

Based on TikTok, the platform has removed violative content and prohibited associated keywords and search suggestions. The company said it was dedicated to keeping the platform safe and investing in strengthening compliance measures.

Digital Trading Activities

Investigations also discovered communities with up to 9,000 members selling the experimental drug using Telegram's built-in search feature, which functions like a online catalog. Typing “retatrutide” immediately displays groups with thousands of members, populated with photos of weight loss, positive reviews and step-by-step instructions for preparing or injecting at residence.

After moments of entering one community, a vendor shared contact information, where most transactions occur. The seller sent an guidebook and promised shipping within 48 hours. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about body mass, health issues or past usage.

Item Information and Pricing

Inside these communities, posts display black plastic packages with Royal Mail labels, claiming to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled injectors usually priced at £160 for 20mg. When questioned how much time a pen should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for Telegram stated it regularly moderated dangerous content on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are injecting substances they can’t verify. Even if the research behind this drug is sound, these digital versions may not contain what they advertise,” stated a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in interest to recent price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But counterfeit injections are extremely risky. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she said.

Her team has previously seen patients harmed by personal administration from unverified suppliers. “We understand the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may expose patients to potentially serious medical dangers”.